Clinical trial sponsors are constantly seeking ways to accelerate study timelines, thereby more rapidly delivering therapeutics to patients and optimizing return on R&D investment. Accelerating clinical trials means acquiring high-quality data faster. It means developing protocols, configuring technology, activating research...
In a digital world, people are increasingly concerned about data privacy. The pharmaceutical industry is no exception. The growing importance of data privacy requires companies to prioritize effective patient consent and preference management. Personalized medicine, electronic health records, and an...
Patient recruitment remains a critical challenge in clinical trials, with up to 80% of studies failing to meet enrollment timelines, causing costly delays. With the data revolution transforming the healthcare industry, it seemed that clinical trials would see a new...
While the life science industry began piloting decentralized clinical trials (DCTs) more than 15 years ago, the COVID 19 pandemic led to tremendous growth, primarily out of necessity. As the world shut down, DCTs became the only viable option for...
